4. Overview
• Primary bone cancers make up less than 0.2% of all cancers.
• In 2014, an estimated 3020 people were diagnosed in the US and
1460 will die from the disease.
• Osteosarcoma (35%), chondrosarcoma (30%) and Ewing’s sarcoma
(16%) are the three most common forms of bone cancer.
• Rare: High grade undifferentiated pleomorphic sarcoma (UPS) of
bone, fibrosarcoma, chordoma and giant cell tumor of bone (GCTB).
6. Chondrosarcoma
• These characteristically produce cartilage matrices from neoplastic tissue
devoid of osteoid
• More common in older adults
• Pelvis and proximal femur are most common sites
• Conventional chondrosarcoma of the bone makes up 85% of all
chondrosarcomas
• It is divided as follows:
1. Primary or central lesions arising from normal appearing bone
preformed from cartilage
2. Secondary or peripheral tumors arising from pre-existing benign cartilage
lesions such as enchondromas or cartilaginous portion of
osteochondroma
13. NCCN Recommendations
• Histologic grade and tumor locations are the most important variable
determining choice of primary treatment.
• Wide excision or intralesional excision with or without adjuvant should be
considered for resectable low grade and intracompartmental lesions.
• Wide excision is preferred treatment for pelvic low grade
chondrosarcomas.
• High grade (grade II, III), clear cell or extracompartmental lesions, if
resectable, should be treated with wide excision with negative margins.
• Postop treatment with proton and/or photon beam RT may be used in
chondrosarcomas of skull base and axial skeleton.
• RT may be considered in unresectable cases or for palliation.
15. Chordoma
• They arise from embryonic remnants of notochord
• More common in older adults
• Predominantly arise in the axial skeletal with the sacrum (50-60%), skull
base (25-35%) and spine (15%)
• Classified into 3 variants: conventional, chondroid and dedifferentiated
• Conventional: most common, lack cartilaginous or mesenchymal
components
• Chondroid present with cartilage remnants and features of chordoma
• Dedifferentiated chordomas have features of high grade pleomorphic
spindle cell soft tissue sarcoma, follow aggressive course
• Chordomas of spine and sacrum present with localized deep pain or
radiculopathy, cervical ones cause airway obstruction or dysphagia or
present with oropharyngeal mass
19. Ewing’s sarcoma
• Ewing’s sarcoma is the second most frequent primary malignant bone
cancer, after osteosarcoma.
• It is a small round-cell tumor typically arising in the bones.
• It is slightly more common in boys (55:45 male:female ratio).
• Most common age of diagnosis is the second decade of life, although
20%–30% of cases are diagnosed in the first decade.
20.
21. Localization
• Ewing’s sarcoma demonstrates a predilection for
the trunk and long bones.
• In the truncal skeleton, the pelvis predominates,
followed by the scapula, vertebral column, ribs and
clavicle.
• Of the long bones, the most common site is the
femur, followed by the humerus, tibia and bones of
forearm in that order.
22.
23. Localization
• As opposed to osteosarcoma, Ewing’s sarcoma of the
long bones tends to arise from the diaphysis rather than
the metaphysis.
• Ewing’s sarcoma has a strong potential to metastasize.
• Metastases most commonly occur in the lungs and bone.
• More than 10% of patients present with multiple bone
metastases at initial diagnosis. While metastases in the
lungs, bone, bone marrow, or a combination thereof are
detectable in approximately 25% of patients, metastases
to lymph nodes are rare.
• Extra-skeletal Ewing’s sarcomas present with rapid
growth and frequent distant metastases, similarly to
Ewing’s sarcoma of bone.
24. Symptoms
Ewing’s sarcoma typically progresses quite rapidly.
Skeletal lesions typically progress to large tumors
that form in soft tissues within a few weeks.
The earliest symptom is pain. At first, the pain can be
intermittent and mild, but rapidly progresses to the
point at which it becomes so intense as to require the
use of analgesic drugs.
When the tumor is vertebral or pelvic in origin, the
pain may be accompanied by paresthesia and treated
by irradiation.
25. Symptoms
• Pain often does not completely disappear during the night
• Pain without defined trauma adequate to explain the symptoms,
lasting longer than a month, continuing at night, or with any other
unusual features should therefore prompt early imaging studies.
28. Imaging Evaluation of Ewing Sarcoma
Imaging in Ewing sarcoma can help to :
(a) detect and accurately assess the extent of
disease prior to treatment.
(b) evaluate for the presence of metastatic or
recurrent disease.
• (c) monitor therapy response.
29. Imaging Evaluation of Ewing Sarcoma
• Conventional radiography and magnetic resonance
(MR) imaging of the primary tumor.
• Tomography (CT) to evaluate for pulmonary
metastases.
• Bone scintigraphy to identify osseous metastases.
30. DIAGNOSTIC IMAGING
• PLAIN RADIOGRAPH :
• The initial imaging investigation of a
suspected bone tumor is a radiograph in
two planes. Tumor-related osteolysis and
periosteal reactions suggest a diagnosis of
primary malignant tumor.
Periosteal reactions, the reactive
osteogenesis of the periosteum, are
caused by extra-osseous extension of the
tumor.
31. DIAGNOSTIC IMAGING
Several types of periosteal reactions have been
observed:
an ‘onion skin’ or ‘onion-peel appearance’ is a
prominent multi-layered reaction,
a ‘sunburst’ or ‘spiculae’ pattern is a perpendicular
reaction, while ‘Codman’s triangle’ is a triangular lifting
of the periosteum from the bone at the site of
detachment.
Typically, Ewing’s sarcoma appears as an ill-defined,
permeative, or focally moth-eaten, destructive
intramedullary lesion accompanied by a periosteal
reaction (‘onion skin’) that affects the diaphyses of
long bones.
The sunburst type of periosteal reactions can present,
but is less common in comparison with its occurrence in
osteosarcoma.
32. MRI
• The most precise definition of the local
extent of bone tumors, including the degree
of expansion into the intra medullary
portion and the relationship of the lesion to
adjacent blood vessels and nerves, is
provided by MRI.
• When malignant bone tumors are
suspected, MRI is routinely performed for
staging and surgical planning.
• MRI is particularly important in the imaging
of Ewing’s sarcoma.
33. MRI
MRI typically demonstrates lesions that involve large segments of the
intramedullary cavity, which extend beyond the area indicated by plain
radiographs.
MRI can also evaluate the extent of soft tissue masses, which can be quite
large.
MRI is widely used to assess responses to neoadjuvant
chemotherapy or irradiation, because regression of the extra skeletal
tumor mass can be precisely defined.
Currently, MRI is the standard imaging method for such evaluation. Recent
studies have demonstrated, however, that PET, thallium-201 scintiography
and dynamic MRI provide more valuable information than MRI for
assessment of therapeutic responses.
35. Prognostic Factors
• Favorable:
• Distal site of primary disease
• Tumor volume <100 ml
• Normal LDH at presentation
• Absence of metastatic disease at presentation
ESFT in spine and sacrum has worse prognosis.
44. Radiology
• Lytic lesion
• Epipyseal
• Eccentric or central
• Narrow zone transition
• Cortical thinning
• expansile
• No sclerotic margin
45. Imaging
• Occ. Cortical breakthrough
• +/- soft tissue mass
• Extend to subarticular cortex
• Typically no host response
• Often large @ presentation
46. Other modalities
• CT
• Integrity cortical rim
• MRI
• Assess subchondral breakthrough
• Bone Scan
• Suspect multicentri loci
• ie. HAND
Overview of clinical characteristics and therapeutic options in all subtypes of chondrosarcoma of bone
Histology of grade I, II, and III chondrosarcoma. While cellularity is low in grade I chondrosarcoma (A) with chondroid matrix and absent mitoses, in grade II chondrosarcoma (B) mitoses are found (inset). In grade III chondrosarcoma (C), a high cellularity with muco-myxoid matrix changes is seen with cytonuclear atypia (hematoxylin and eosin staining, ∼500×).
Histology of rare chondrosarcoma subtypes. (A): Histology of dedifferentiated chondrosarcoma with a sharp interface between conventional chondrosarcoma (left) and anaplastic sarcoma (right). (B): Mesenchymal chondrosarcoma with undifferentiated small blue round cells (below) and cartilage differentiation (top). (C): Clear cell chondrosarcoma demonstrating chondrocytes with abundant clear cytoplasm, cartilaginous matrix, and deposition of osteoid. (hematoxylin and eosin staining, ∼500×)
Radiological presentation of a conventional low-grade chondrosarcoma. (A): Conventional low-grade chondrosarcoma in the proximal humerus with chondroid mineralization on conventional radiograph. (B): Discrete endosteal scalloping of the anterior cortex is seen on the T1-weighted magnetic resonance image. (C): Axial T1-weighted magnetic resonance image with fat suppression after i.v. contrast injection demonstrates the typical peripheral ring-and-arc pattern of enhancement. No soft tissue extension is noted.
Flowchart of the surgical management of central and peripheral chondrosarcoma.
Flowchart of the surgical management of local recurrence in central chondrosarcoma.
Histologic and immunohistochemical features of Ewing’s sarcoma/pPNET. (A): Classic Ewing’s sarcoma appears as sheets of monotonous round cells. (Hematoxylin and eosin, original magnification 200×.) (B): The cells have scanty cytoplasm and round nuclei with evenly distributed finely granular chromatin and inconspicuous nucleoli. (Hematoxylin and eosin, original magnification 400×.) (C): Strong, diffuse membrane staining is observed with the O13 monoclonal antibody to p30/32MIC2 (CD99). (Immunoperoxidase, original magnification 400×.)
The reciprocal translocation between chromosomes 11 and 22 results in the formation of an ews-fli1 fusion gene on the abnormal chromosome 22 that codes for a chimeric transcription factor with the N-terminal transcriptional regulatory domain deriving from ews and the ets-specific DNA-binding domain derived from fli1.